Different Dose Levels of a Respiratory Syncytial Virus Maternal Vaccine Candidate (RSVPreF3) Administered to Non-pregnant Women in a Randomized Clinical Trial Are Immunogenic and Well Tolerated

Authors
Category Primary study
JournalOpen Forum Infect. Dis.
Year 2020
This article has no abstract
Epistemonikos ID: 67e8b49b9b7e5cc3ef90085cf14614dedf692d99
First added on: May 08, 2021